DGAP-News: Marinomed Biotech AG continues its growth path and reports strong financials in H1 2022
DGAP-News: Marinomed Biotech AG / Key word(s): Half Year Report Marinomed Biotech AG continues its growth path and reports strong fin...
Stay updated with breaking news from Convertible Notes Funding Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Marinomed Biotech AG / Key word(s): Half Year Report Marinomed Biotech AG continues its growth path and reports strong fin...
DGAP-News: Marinomed Biotech AG / Key word(s): Agreement Marinomed to pause issuing of tranches of Convertible Notes Funding Program ...
DGAP-News: Marinomed Biotech AG / Key word: Agreement Marinomed to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green 21.07.2022 / 07:45 The... | July 21, 2022
DGAP-News: Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose
DGAP-News: Marinomed Biotech AG / Key word(s): Quarter Results Marinomed Biotech AG reports strong 1st quarter 2022: continued growth...